Everything below concerns pentadecapeptide. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-03-31. Where a claim depends on a specific study, the study is described rather than over-claimed.
Most published work on BPC-157 consists of preclinical studies, including rodent models of tissue injury, gastrointestinal lesions, and vascular or tendon damage, together with in vitro cell assays. Reviews frequently note that the mechanisms proposed in these papers remain incompletely characterised and that findings have not been confirmed in large randomised human trials. The compound is widely sold as a research chemical rather than a licensed medicine, and labels commonly carry a statement that it is not for human use. Whether any of the reported animal effects translate to humans is an open question rather than an established result.
Terminology in the literature is not fully standardised. Papers and product listings use BPC-157, BPC 157, and the longer phrase stable gastric pentadecapeptide BPC 157 interchangeably, and synonyms such as bepecin or PL 14736 appear in older or company-linked publications. Purity claims and reported masses can also differ between sources because peptide preparations may include counterions, residual solvents, or bound water. This variability complicates direct comparison of results across studies and makes the exact identity and grade of a given sample worth verifying. Discussions of the compound should therefore specify the source, salt form, and stated purity where those are known.
BPC-157 is a synthetic peptide composed of fifteen amino acid residues, with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. Its name derives from body protection compound, a term used for a protein fraction identified in human gastric juice. Researchers in Zagreb first reported the pentadecapeptide in the early 1990s and described it as a stable fragment of that larger protein. The compound is also catalogued as PL 14736 and, in some commercial contexts, as bepecin. Its molecular formula is C62H98N16O22 and its monoisotopic mass is approximately 1419 daltons.
BPC-157 is commonly supplied as a lyophilized powder, a freeze-dried solid that is reconstituted before use in laboratory work. As a short peptide, it dissolves readily in water and in aqueous buffer solutions, and stock solutions are typically prepared in water or a mild buffer. The chain contains several proline and acidic residues, which influence how it behaves in solution. Because the solid can take up moisture, weighing and handling are usually performed under low-humidity conditions. Its solubility class is described as freely soluble in water rather than requiring an organic solvent.
Dry powder is generally stored at low temperature, with minus twenty degrees Celsius or colder advised for extended retention. Reconstituted solutions are less stable than the solid form and are normally kept cold and shielded from repeated freeze-thaw cycles. Light exposure is avoided because some peptides degrade under ultraviolet radiation. The exact rate of degradation depends on concentration, pH, and the presence of salts, so a single shelf life does not apply to every preparation. Reported stability figures should be read as indicative of typical handling rather than as universal constants.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C62H98N16O22 | Computed for the free peptide |
| Monoisotopic mass | Approximately 1419 Da | Reported values shift with counterion and hydration |
| Residue count | 15 amino acids | Sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val |
| Origin | Fragment of human gastric juice protein | First described in early 1990s research reports |
| Common synonyms | BPC 157; PL 14736; bepecin | Naming varies across papers and catalogues |
The molecule carries 15 residues, a molar mass near 1419.5 g/mol, and the formula C62H98N16O22. Its structure features a proline-rich central region, a pair of adjacent aspartic acid residues, and no cysteine. The absence of cysteine means no disulfide bonds can form, which simplifies refolding and reconstitution. Suppliers usually ship the material as a freeze-dried powder that appears white to off-white. It dissolves readily in water and in saline solutions.
Published storage guidance follows general peptide practice rather than product-specific studies. The dry powder is typically kept at minus 20 degrees Celsius, away from light and moisture. Once reconstituted, solutions are generally refrigerated and used over days to weeks, because the aqueous environment slowly promotes hydrolysis and oxidation. Long-term data on degradation rates or breakdown products are sparse. Stated shelf lives from different producers vary widely, reflecting the absence of a shared reference standard.
BPC-157 is a synthetic peptide built from fifteen amino acid residues. Its sequence comes from a larger protein fragment that researchers isolated from human gastric juice and described as a body protection compound. The fragment contains glycine, glutamic acid, five prolines, lysine, alanine, two aspartic acids, leucine, and valine. The number 157 in the name refers to the position of the stretch within the parent protein. Material used in laboratories is manufactured rather than extracted from stomach fluid.
Analytical results depend on the column, gradient, and detector wavelength chosen by the laboratory, so purity values from different sources are not always directly comparable. Water content, counterion form, and residual trifluoroacetate affect both mass and purity calculations. Microbiological and endotoxin testing are separate from chemical purity and are not covered by a standard chromatographic run. Buyers evaluating a material typically request the full method description rather than a single purity figure.
Lyophilized peptide powder is generally stored at minus twenty degrees Celsius or lower and kept away from light and moisture. Under these conditions degradation is slow, and sealed vials remain stable for extended periods. Once dissolved, the material is less stable, particularly in aqueous buffers near neutral pH, where hydrolysis and oxidation proceed faster. Solutions are usually kept cold and used within days to weeks. Repeated freeze-thaw cycles are avoided because they encourage aggregation.
Identity and purity are established using reversed-phase high-performance liquid chromatography, which separates the peptide from related impurities and yields a percentage purity. Mass spectrometry, typically with electrospray ionization, confirms the molecular mass against the expected value. Amino acid analysis or peptide mapping provides additional sequence confirmation. These methods are complementary, since chromatography measures how much material is present while mass spectrometry verifies what that material is. A certificate of analysis normally reports both.
Material of this kind is sold for laboratory research, and labels typically state that it is not intended for human or veterinary use. In many countries it is not an approved medicine, and sports antidoping rules place it among prohibited non-approved substances. Buyers commonly review a certificate of analysis, an independent test report, and the declared storage conditions. Batch-to-batch variation in purity and in counterion content is possible, and how much that variation affects experimental outcomes remains an open question.
Lyophilized peptide is normally kept at minus twenty degrees Celsius or colder, away from light and moisture. Powder held under those conditions is widely treated as stable for long periods, although published stability studies for this exact sequence are sparse and often come from suppliers rather than independent laboratories. Once dissolved, solutions are generally handled cold and used within a short window, because peptide bonds can hydrolyze over time. Repeated freeze-thaw cycles are usually avoided to limit losses, and exact shelf-life figures depend on the buffer and the concentration involved.
Most published findings come from rodent models, where the peptide has been examined in wound-healing, gastrointestinal-lesion, tendon, and vascular-injury preparations. A smaller number of early human studies have been reported, chiefly in inflammatory bowel conditions, but the public record is short and has not led to marketing approval in the United States or the European Union. Reviewers therefore classify the compound as investigational, and whether animal results carry over to people remains an open question rather than a settled one.
Outside laboratory supply channels, the peptide is sold as a research chemical, a category that carries no requirement to demonstrate purity, identity, or freedom from contamination. Because it is not an approved medicine, products labeled BPC-157 sit in a regulatory gap in many countries, and actual content may differ from the label. Sports organizations list it among prohibited substances, so its presence in an athlete's sample can produce a doping finding regardless of how the material was obtained.
BPC-157 is a synthetic peptide of fifteen amino acids, written as GEPPPGKPADDAGLV, whose sequence matches part of a larger protein identified in human gastric juice. That parent protein was described in stomach-secretion research, and the fifteen-residue fragment was named body protection compound, which gives the peptide its common label. Material used in experiments is produced by solid-phase peptide synthesis rather than extracted from tissue. The reported molecular weight is about 1419 daltons, and the chain contains several proline residues, a feature that appears in discussions of its resistance to enzymatic breakdown.
A method of providing experimental therapeutics prior to final FDA approval for use in humans. This procedure is used with very sick individuals who have no other treatment options. Often, case-by-case approval must be obtained from the FDA for "compassionate use" of a drug or therapy. (NLM) Compassionate use trial
== SC == sc – (s) Sardinian language (ISO 639-1 code) Sc – (s) Scandium SC (s) Cruiser Submarine (US Navy hull classification) c Saint Kitts and Nevis (FIPS 10-4 country code; from Saint Christopher) Seychelles (ISO 3166 digram) South Carolina (postal symbol) SCA (i) Service Contract Act Sexual Compulsives Anonymous Society for Creative Anachronism SCAP – (a) Supreme Commander Allied Powers (Allied occupation of Japan) sccm – (s) Standard cubic centimetre per minute (unit of measurement of fluid flow) sccs – (s) Standard cubic centimetre per second (unit of measurement of fluid flow) scfh – (s) Standard cubic foot per hour (unit of measurement of fluid flow) scfm – (s) Standard cubic foot per minute (unit of measurement of fluid flow) scfs – (s) Standard cubic foot per second (unit of measurement of fluid flow) SCG – (s) Serbia and Montenegro (ISO 3166 trigram; defunct since 2006) SCHIMS – (i) Soldier Combat Helmet Identification Marking System SCHIP – (a) State Children's Health Insurance Program (U.S.; often pronounced "ess-chip") SciFi – Science Fiction sCJD – (i) Sporadic Creutzfeldt–Jakob disease SCM – (i) Surface Contamination Module SCMODS – (s) State, County, Municipal Offender Data System SCN – (p) Suprachiasmatic Nucleus SCNT – (i) Somatic Cell Nuclear Transfer SCO (i) Santa Cruz Operation (initials later used by SCO Group) (s) Scotland (FIFA trigram; not eligible for an ISO 3166 or IOC trigram) (a) Shanghai Cooperation Organisation SCOTUS – (a) Supreme Court of the United States SCR – (s) Seychelles rupee (ISO 4217 currency code) SCRAM – (a) Safety Control Rod Axe Man SCS (i) Scan Correlated Shift Soil Conservation Service SCSI (a) Small Computer System Interface ("scuzzy") (i) Strategic and Combat Studies Institute SCT – (s) Scattered Sky (METAR Code) SCTP – (i) Stream Control Transmission Protocol Scuba – (a) Self Contained Underwater Breathing Apparatus SCUF – Slow Continuous Ultrafiltration SCUFN – (i) Sub-Committee on Undersea Feature Names (of GEBCO)
Instead the bottler may identify only the general geographical area of the source, or simply market the product using their own brand name without identifying their source. This may, in some cases, give the independent bottling company the flexibility to purchase from multiple distillers without changing their labels.
Sources: en.wikipedia.org
=== The consolidation of the democratic system === The government of Felipe González understood that to consolidate the democratic regime in Spain it was necessary to put an end to its two main enemies: the "coup" and "terrorism". As for the former, a series of measures aimed at the "professionalization" of the Army and its subordination to civilian power were put in place with which the idea of an "autonomous" military power was completely discarded. The government still had to face a last coup attempt in June 1985 which was dismantled by the intelligence services and that was not reported to the public until more than ten years later. Following this case, the coup attempts disappeared from Spanish political life. As for the anti-terrorist policy, the first socialist governments maintained the reinsertion of imprisoned separatists ─ many of them belonging to the ETA political-military faction ─ who condemned ETA's violence and dissociated themselves from it, but in the face of under his mandate the "dirty war" against ETA led by the GAL was increased, a "group initially made up of members of the State security forces and later swelled by some Spanish and foreign mercenaries linked to the former Political-Social Brigade of Francoism". Until 1987, the attacks of the GAL caused 28 fatalities, the vast majority of them in the so-called "French sanctuary".
=== Muscle repair === Stem cells have successfully been used to ameliorate healing in the heart after myocardial infarction in dogs. Adipose and bone marrow derived stem cells were removed and induced to a cardiac cell fate before being injected into the heart. The heart was found to have improved contractility and a reduction in the damaged area four weeks after the stem cells were applied. In 2007, a trial was underway for a patch made of a porous substance onto which the stem cells are "seeded" in order to induce tissue regeneration in heart defects. Tissue was regenerated and the patch was well incorporated into the heart tissue. This is thought to be due, in part, to improved angiogenesis and reduction of inflammation. Although cardiomyocytes were produced from the mesenchymal stem cells, they did not appear to be contractile. Other treatments that induced a cardiac fate in the cells before transplanting had greater success at creating contractile heart tissue. 2018 research, such as the European nTRACK research project, aims to demonstrate that multimodal nanoparticles can structurally and functionally track stem cell in muscle regeneration therapy. The idea is to label stem cells with gold nano-particles that are fully characterised for uptake, functionality, and safety. The labelled stem cells will be injected into an injured muscle and tracked using imaging systems. However, the system still needs to be demonstrated at lab scale.
=== Games about the Cold War === Twilight Struggle is a 2005 card-based board game by GMT Games that depicts the events of the entire Cold War, starting from Joseph Stalin to Ronald Reagan. The game was turned into a video game in 2016.
Trump also signed the One Big Beautiful Bill Act into law, which permanently extended the tax cuts introduced in the first Trump administration, while increasing the deficit by around $3 trillion by 2034. Trump has also overseen a series of tariff increases and pauses, which led to retaliatory tariffs from other countries and stock market volatility. In international affairs, Trump has further pursued an expansionist and aggressive foreign policy, including the greater use of military force. His administration increased support for Israel in the Gaza war, struck Houthi targets in Yemen from March to May 2025 and aided Israel in the June 2025 Twelve-Day War, during which he carried out strikes on Iranian nuclear sites. In early October 2025, Trump's plan for a Gaza ceasefire deal between Israel and Hamas was signed. Trump has authorized a series of strikes on suspected drug traffickers in the Caribbean Sea, the legality of which is widely disputed under both U.S. and international law, and subsequently ordered a military intervention to overthrow and capture Nicolás Maduro, the disputed president of Venezuela, alleging that the Maduro government had links to narco-terrorist networks and conspired to flood the United States with cocaine. In February 2026, he launched a major attack on Iran with Israel with the stated goal of regime change, including the assassination of the Supreme Leader of Iran Ali Khamenei, which led to the 2026 Strait of Hormuz crisis and fuel crisis. As in his first presidency, Trump initiated the withdrawal of the U.S.
Sources: en.wikipedia.org
BPC-157 is a synthetic fifteen-amino-acid peptide whose sequence corresponds to a fragment of a protein found in human gastric juice. It is studied mainly in preclinical research and is not an approved pharmaceutical product in major markets. Materials sold for laboratory use are typically labelled as research chemicals.
No medicines regulator in the United States or the European Union has approved BPC-157 as a therapeutic product. Presenting it as a drug or as a dietary supplement ingredient would generally not match its regulatory status. Availability as a research chemical does not imply clinical approval.
Published reports rest largely on animal models and cell culture rather than controlled human trials. Review articles describe the proposed mechanisms as incompletely understood. Conclusions about effects in humans therefore remain tentative.
The lyophilized powder is normally kept at minus twenty degrees Celsius or colder. Solutions are held at refrigerator temperature or below and protected from light. Repeated freezing and thawing is avoided because it can promote aggregation or loss of activity.